Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 29, 2014Alimentary Pharmacology & TherapeuticsOpen Access

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

View Full Paper
Ask AI
Bookmark
Share

Authors

LFLarysa FedchukSorbonne UniversitéFNFabio NascimbeniUniversity of Modena and Reggio EmiliaRPR. PaisBrooke Army Medical Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fedchuk et al. (2014) studied this question.

synapsesocial.com/papers/6a7dc93dd491aa75eb150e6ahttps://doi.org/10.1111/apt.12963
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease2005 · 3,547 citations
  2. 2Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease2010 · 1,926 citations
  3. 3Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population #2009 · 389 citations
  4. 4The Product of Fasting Glucose and Triglycerides As Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects2008 · 2,637 citations